Financhill
Sell
39

ILAG Quote, Financials, Valuation and Earnings

Last price:
$0.96
Seasonality move :
-19.91%
Day range:
$0.92 - $0.98
52-week range:
$0.33 - $1.35
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.05x
Volume:
6.5K
Avg. volume:
15.9K
1-year change:
33.99%
Market cap:
$17.3M
Revenue:
$6.4M
EPS (TTM):
--
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $11.1M $11.2M $12.5M $12.2M $6.4M
Revenue Growth (YoY) -22.79% 0.81% 11.8% -3.07% -47%
 
Cost of Revenues $10M $9.6M $11.2M $10M $5.8M
Gross Profit $1.1M $1.6M $1.3M $2.2M $633.3K
Gross Profit Margin 10.05% 14.07% 10.46% 18.06% 9.83%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.5M $2.6M $3.1M $4.3M $4.5M
Other Inc / (Exp) $129K $21.8K $411K $581.3K $203.6K
Operating Expenses $2.5M $2.6M $3.1M $4.3M $4.5M
Operating Income -$1.4M -$1M -$1.7M -$2.1M -$3.9M
 
Net Interest Expenses $25.5K $28.9K $57.6K $119.7K --
EBT. Incl. Unusual Items -$1.3M -$1M -$1.4M -$1.7M -$3.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- $56.2K
Net Income to Company -$1.3M -$1M -$1.4M -$1.7M -$3.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$1.3M -$1M -$1.4M -$1.7M -$3.5M
 
Basic EPS (Cont. Ops) -$0.07 -$0.06 -$0.08 -$0.11 -$0.19
Diluted EPS (Cont. Ops) -$0.07 -$0.06 -$0.08 -$0.11 -$0.19
Weighted Average Basic Share $18.1M $18.1M $18.1M $15.3M $18.1M
Weighted Average Diluted Share $18.1M $18.1M $18.1M $15.3M $18.1M
 
EBITDA -$968.4K -$720.6K -$1.1M -$1.2M -$2.7M
EBIT -$1.3M -$986.2K -$1.3M -$1.5M -$3.4M
 
Revenue (Reported) $11.1M $11.2M $12.5M $12.2M $6.4M
Operating Income (Reported) -$1.4M -$1M -$1.7M -$2.1M -$3.9M
Operating Income (Adjusted) -$1.3M -$986.2K -$1.3M -$1.5M -$3.4M
Period Ending 2020-12-23 2021-12-23 2022-12-23 2023-12-23
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $11.1M $11.2M $12.5M $12.2M $6.4M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) $11.1M $11.2M $12.5M $12.2M $6.4M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2020-12-23 2021-12-23 2022-12-23 2023-12-23 2024-12-23
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $1.1M $302.4K $131.1K $9.2M $4.5M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $553.8K $789.9K $1.1M $1.6M $445.5K
Inventory $3.4M $4.4M $5.1M $4.5M $5M
Prepaid Expenses $67.9K $166.6K $306.7K $487.7K $1.9M
Other Current Assets -- -- -- -- --
Total Current Assets $5.4M $6.1M $7.1M $16M $12.1M
 
Property Plant And Equipment $3.1M $2.4M $2.2M $5.8M $6.1M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $8.5M $8.5M $9.3M $21.8M $18.3M
 
Accounts Payable $1.3M $1.3M $1.9M $396.6K $324.6K
Accrued Expenses $804.9K $901.4K $1.5M $497.5K $465.3K
Current Portion Of Long-Term Debt $142.3K $720.5K $762.8K $201.2K $129.7K
Current Portion Of Capital Lease Obligations $422.5K $386.4K $447.3K $531.8K $279.3K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $3M $3.5M $4.9M $1.8M $1.4M
 
Long-Term Debt -- $349.4K $498.4K $417.8K $334.3K
Capital Leases -- -- -- -- --
Total Liabilities $4.1M $4.4M $5.8M $2.4M $1.9M
 
Common Stock $1.3K $1.3K $1.3K $1.8K $1.8K
Other Common Equity Adj -$250.7K $323K $375.3K -$45.6K -$260.6K
Common Equity $4.4M $4.1M $3.5M $19.5M $16.4M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $4.4M $4.1M $3.5M $19.5M $16.4M
 
Total Liabilities and Equity $8.5M $8.5M $9.3M $21.8M $18.3M
Cash and Short Terms $1.1M $302.4K $131.1K $9.2M $4.5M
Total Debt $142.3K $1.1M $1.3M $619K $464K
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $1.1M $302.4K $131.1K $9.2M $4.5M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $553.8K $789.9K $1.1M $1.6M $445.5K
Inventory $3.4M $4.4M $5.1M $4.5M $5M
Prepaid Expenses $67.9K $166.6K $306.7K $487.7K $1.9M
Other Current Assets -- -- -- -- --
Total Current Assets $5.4M $6.1M $7.1M $16M $12.1M
 
Property Plant And Equipment $3.1M $2.4M $2.2M $5.8M $6.1M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $8.5M $8.5M $9.3M $21.8M $18.3M
 
Accounts Payable $1.3M $1.3M $1.9M $396.6K $324.6K
Accrued Expenses $804.9K $901.4K $1.5M $497.5K $465.3K
Current Portion Of Long-Term Debt $142.3K $720.5K $762.8K $201.2K $129.7K
Current Portion Of Capital Lease Obligations $422.5K $386.4K $447.3K $531.8K $279.3K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $3M $3.5M $4.9M $1.8M $1.4M
 
Long-Term Debt -- $349.4K $498.4K $417.8K $334.3K
Capital Leases -- -- -- -- --
Total Liabilities $4.1M $4.4M $5.8M $2.4M $1.9M
 
Common Stock $1.3K $1.3K $1.3K $1.8K $1.8K
Other Common Equity Adj -$250.7K $323K $375.3K -$45.6K -$260.6K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $4.4M $4.1M $3.5M $19.5M $16.4M
 
Total Liabilities and Equity $8.5M $8.5M $9.3M $21.8M $18.3M
Cash and Short Terms $1.1M $302.4K $131.1K $9.2M $4.5M
Total Debt -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$1.3M -$1M -$1.4M -$1.7M -$3.5M
Depreciation & Amoritzation $283.9K $265.7K $259.1K $303.3K $693.5K
Stock-Based Compensation -- -- -- -- $667K
Change in Accounts Receivable $184.4K -$154.9K -$333.6K -$429.3K $1.1M
Change in Inventories $236K -$683.7K -$712.9K $535.2K -$586.6K
Cash From Operations -$289.4K -$1.6M -$1M -$4.2M -$3.2M
 
Capital Expenditures $112.8K $221.8K $9.8K $4.2M $1.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$112.8K -$221.8K -$9.8K -$4.2M -$1.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- $927.5K $191.3K $2M --
Long-Term Debt Repaid -$31K -$32K -$33K -$2.6M -$155K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $753.9K $153.9K $718K -- --
Cash From Financing $204.7K $1M $876.3K $17.4M -$155K
 
Beginning Cash (CF) $1.3M $1.1M $302.4K $131.1K $9.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$197.5K -$771.4K -$172.4K $9M -$4.7M
Ending Cash (CF) $1.1M $302.4K $131.1K $9.2M $4.5M
 
Levered Free Cash Flow -$402.2K -$1.8M -$1M -$8.4M -$4.5M
Period Ending 2020-12-23 2021-12-23 2022-12-23 2023-12-23
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$289.4K -$1.6M -$1M -$4.2M -$3.2M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2020-12-23 2021-12-23 2022-12-23 2023-12-23 2024-12-23
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock